PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Infection 766,637 Disease Target ACY1 51 1 0.00 -0.99 0.02 0.52
BMP-4 1,255 Target Target ACVR1B 23 1 0.01 -0.98 0.04 0.68
Gout 8,355 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.63
Ovarian Cancer 33,996 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.59
Arthritis 128,324 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.57
Stroke 146,992 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.56
Cholesterol 182,390 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.56
Carcinoma 433,099 Disease Target ACVR1B 23 1 0.00 -0.98 0.04 0.54
Hormone Replacement Therapy 11,020 Disease Target ACTG1 41 1 0.00 -0.99 0.02 0.61
Beta-Tubulin 4,870 Target Target ACT-2 127 1 0.00 -1.00 0.01 0.62
Gonorrhea 5,642 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.61
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target ACT-2 127 1 0.00 -1.00 0.01 0.61
CD14 9,941 Target Target ACT-2 127 1 0.00 -1.00 0.01 0.60
Arrhythmia 29,330 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.57
Analgesia 44,857 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.56
CD4 112,219 Target Target ACT-2 127 1 0.00 -1.00 0.01 0.54
Cancer 1,053,491 Disease Target ACT-2 127 1 0.00 -1.00 0.01 0.49
CNTF 1,613 Target Target ACRP30 102 1 0.00 -0.99 0.01 0.65
Platelet Aggregation 25,460 Disease Target ACRP30 102 1 0.00 -1.00 0.01 0.58
Lung Cancer 91,416 Disease Target ACRP30 102 1 0.00 -1.00 0.01 0.55
CCL4 5,638 Target Target ACAT2 145 1 0.00 -1.00 0.01 0.61
Psychiatric Disorder 6,440 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.61
Androgen Receptor 12,918 Target Target ACAT2 145 1 0.00 -1.00 0.01 0.59
Diarrhea 51,986 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.55
Prostate Cancer 71,064 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.55
Schizophrenia 77,034 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.54
Cancer 1,053,491 Disease Target ACAD8 11 1 0.00 -0.95 0.09 0.54
Social Anxiety 3,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.63
Hormone Replacement Therapy 11,020 Disease Target AACT 109 1 0.00 -1.00 0.01 0.60
CEA 17,022 Target Target AACT 109 1 0.00 -1.00 0.01 0.58
Bronchitis 18,336 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Platelet Aggregation 25,460 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Chronic Obstructive Pulmonary Disease 27,780 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Colon Cancer 30,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Hearing Loss 30,622 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Osteoarthritis 36,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Prostate Cancer 71,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Lung Cancer 91,416 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
CD4 112,219 Target Target AACT 109 1 0.00 -1.00 0.01 0.54
Anxiety 113,510 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Tuberculosis 146,217 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Diabetes 332,602 Disease Target AACT 109 1 0.00 -1.00 0.01 0.52
Infection 766,637 Disease Target AACT 109 1 0.00 -1.00 0.01 0.50
CD4 112,219 Target Target A1M 59 1 0.00 -0.99 0.02 0.55
Alpha (Prolastin)- FDA 13 Drug Target A1AT 329 1 0.02 -0.96 0.08 0.73
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
CD22 1,591 Target Target A1AT 329 1 0.00 -1.00 0.00 0.63
Ns3 3,189 Target Target A1AT 329 1 0.00 -1.00 0.00 0.61